BILDAMET Tablet 50/850 mg

Adult dose

The dosage of this medication should be individualized not exceeding vildagliptin 100 mg and metformin 2000 mg. Doses above 100 mg of vildagliptin per day are not recommended. 1. For patients with no previous experience of diabetes medication and who find effective blood sugar control difficult with monotherapy: Initial dose of 50/500 mg once daily, one tablet, gradually increase to 50/1000 mg twice daily.

This medication can cause severe lactic acidosis and hypoglycemia, so extreme caution is necessary. It should not be administered to patients with moderate to severe renal impairment, heart failure, acute myocardial infarction, sepsis, or other serious conditions. Additionally, patients who are scheduled to undergo exams using radiocontrast agents containing iodine should discontinue this medication 48 hours before the examination and can resume it only after normal renal function is confirmed. Women who are pregnant or breastfeeding should not use this medication. Irregular meals, strenuous exercise, or co-administration with other drugs may increase the risk of lactic acidosis and hypoglycemia; therefore, caution is warranted. Regular monitoring of liver and kidney function tests is necessary during treatment to ensure no abnormalities occur. Patients with compromised liver function or decreased renal function should avoid or use this medication with close monitoring. This medication is not suitable for type 1 diabetes patients who require insulin treatment or patients with diabetic ketoacidosis. Due to the risk of acute pancreatitis, if symptoms of pancreatitis occur, consult a physician immediately. Alcohol consumption may increase the risk of lactic acidosis; hence, excessive drinking should be avoided during treatment. Symptoms of hypoglycemia may arise; caution is especially needed when taking in conjunction with other hypoglycemic agents or when meals are skipped. During treatment, regularly monitor blood sugar and glycosylated hemoglobin levels to assess treatment effectiveness. Elderly patients or those with poor nutritional status are at higher risk of hypoglycemia and lactic acidosis, necessitating further caution. Treatment with this medication should be suspended for a certain period before and after surgery, and can only be resumed after confirming normal renal function post-surgery. In case of overdose, visit a medical facility immediately for appropriate treatment, and, if necessary, blood dialysis may be helpful. The safety and efficacy of this medication in children and adolescents have not been established, so it should be avoided. If any unusual skin reactions such as blisters or ulcers occur during the use of this medication, inform a physician immediately. Lastly, this medication should be kept out of the reach of children and should not be transferred to other containers.

Serious side effects

• Hives
• angioedema
• blisters and exfoliative skin lesions
• severe swelling
• severe and disabling joint pain
• acute pancreatitis
• hepatitis
• liver dysfunction
• jaundice
• severe allergic reactions

Mild side effects

• Tremor
• headache
• dizziness
• fatigue
• nausea
• gastroesophageal reflux
• diarrhea
• bloating
• chills
• decreased blood sugar

This medication must be stored in a tightly closed container to prevent air and moisture from entering. It is also important to keep it in a cool place below 30 degrees Celsius to maintain its efficacy.

Appearance

Yellow oval film-coated tablet

Package unit

Bottle - 30 tablets/bottle, Bottle - 60 tablets/bottle